The Lifestyle Epidemic: Rising Obesity and Aging Populations as the Core Drivers of Demand in the Multibillion-Dollar Antihypertensive Drugs Market.
The relentless growth of the Antihypertensive Drugs Market, projected to reach over $30 billion in the near future, is not merely driven by pharmacological innovation, but by powerful and concerning global demographic and lifestyle trends. The single most significant driver is the twin epidemic of rising global obesity rates and the universal aging of populations. Obesity is one of the most...
0 Commentarii 0 Distribuiri 5 Views 0 previzualizare